We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+8.45%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$12.4B
AUM Growth
+$271M
(+2.2%)
Cap. Flow
-$478M
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
16.88%
Holding
289
New
32
Increased
64
Reduced
138
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$127M |
| 2 |
Gilead Sciences
GILD
|
+$125M |
| 3 |
PayPal
PYPL
|
+$89.3M |
| 4 |
UnitedHealth
UNH
|
+$88.1M |
| 5 |
GE Aerospace
GE
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$148M |
| 2 |
Kroger
KR
|
+$105M |
| 3 |
Costco
COST
|
+$94.8M |
| 4 |
Lam Research
LRCX
|
+$79.3M |
| 5 |
Charter Communications
CHTR
|
+$73.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.46% |
| 2 | Technology | 16.23% |
| 3 | Industrials | 15.74% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Communication Services | 10.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Alnylam Pharmaceuticals
ALNY
$29.3B
| $18.4M | 0.15% |
271,302
-5,465
| -2% | -$386K |
|
|
FCB
177
DELISTED
FCB Financial Holdings, Inc.
FCB
| $17.6M | 0.14% |
+459,179
| New | +$16.9M |
|
|
CEB
178
DELISTED
CEB Inc.
CEB
| $17.6M | 0.14% |
322,277
+13,255
| +4% | +$793K |
|
|
XLRN
179
DELISTED
Acceleron Pharma
XLRN
| $17.4M | 0.14% |
479,885
-14,315
| -3% | -$474K |
|
|
INXN
180
DELISTED
Interxion Holding N.V.
INXN
| $17M | 0.14% |
470,215
+4,595
| +1% | +$171K |
|
181
Shopify
SHOP
$160B
| $17M | 0.14% |
3,962,650
-3,300
| -0.1% | -$12.6K |
|
182
Brunswick
BC
$5.41B
| $16.9M | 0.14% |
347,066
-24,753
| -7% | -$1.18M |
|
|
WNS
183
DELISTED
WNS Holdings
WNS
| $16.9M | 0.14% |
+564,040
| New | +$16.2M |
|
|
CORV
184
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $16.9M | 0.14% |
5,397,007
+1,487,915
| +38% | +$5.42M |
|
185
BGC Group
BGC
$5.25B
| $16.7M | 0.13% |
2,962,120
-148,883
| -5% | -$850K |
|
186
Prothena Corp
PRTA
$444M
| $16.6M | 0.13% |
277,150
+39,270
| +17% | +$2.11M |
|
|
FLTX
187
DELISTED
Fleetmatics Group PLC
FLTX
| $16.1M | 0.13% |
269,038
+738
| +0.3% | +$40.4K |
|
|
PAY
188
DELISTED
Verifone Systems Inc
PAY
| $15.8M | 0.13% |
1,000,632
-419,685
| -30% | -$7.62M |
|
|
ISLE
189
DELISTED
Isle of Capri Casinos Inc
ISLE
| $14.6M | 0.12% |
+657,264
| New | +$12.4M |
|
|
CHCT
190
Community Healthcare Trust
CHCT
$506M
| $13.8M | 0.11% |
631,590
-21,030
| -3% | -$473K |
|
191
Four Corners Property Trust
FCPT
$2.76B
| $13.3M | 0.11% |
623,065
-259,805
| -29% | -$5.47M |
|
|
ALDR
192
DELISTED
Alder Biopharmaceuticals
ALDR
| $13.2M | 0.11% |
+403,075
| New | +$12.3M |
|
|
NSA
193
DELISTED
National Storage Affiliates Trust
NSA
| $12.9M | 0.1% |
+614,141
| New | +$12.9M |
|
194
Comcast
CMCSA
$88.5B
| $12.6M | 0.1% |
381,310
-40,760
| -10% | -$1.36M |
|
195
Hain Celestial
HAIN
$48.7M
| $11.1M | 0.09% |
+312,056
| New | +$13.7M |
|
|
AIV
196
Aimco
AIV
$384M
| $11M | 0.09% |
+1,800,169
| New | +$10.8M |
|
|
IPHI
197
DELISTED
INPHI CORPORATION
IPHI
| $10.7M | 0.09% |
+246,957
| New | +$9.54M |
|
198
SiteOne Landscape Supply
SITE
$4.42B
| $10.5M | 0.08% |
291,995
+23,505
| +9% | +$888K |
|
199
Marten Transport
MRTN
$1.22B
| $10.4M | 0.08% |
1,239,973
-33,475
| -3% | -$287K |
|
|
PFPT
200
DELISTED
Proofpoint, Inc.
PFPT
| $10.1M | 0.08% |
134,409
-134,560
| -50% | -$9.93M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Westfield Capital Management held 289 positions worth $12.4B, up 2.2% from $12.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Westfield Capital Management withdrew a net $478M in Q3 2016, closing 40 positions and reducing 138 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $148M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.
Against the trend, Westfield Capital Management opened a new position in Abbott worth $126M.
- Westfield Capital Management's largest Q3 2016 buy was Abbott: 2,973,638 shares worth $126M.
- Westfield Capital Management added most to UnitedHealth in Q3 2016, an estimated $88.1M increase.
- Westfield Capital Management's biggest Q3 2016 reduction was Costco, cutting an estimated $94.8M.
- Westfield Capital Management fully exited Teva Pharmaceuticals in Q3 2016, selling an estimated $148M.
- Westfield Capital Management's ten largest holdings make up 17% of its $12.4B portfolio in Q3 2016.
- Westfield Capital Management opened 32 new positions and closed 40 in Q3 2016.
- Westfield Capital Management's portfolio value rose 2.2% quarter-over-quarter to $12.4B.
Based on Westfield Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.